Surgical Oncology Principles Practice Questions

Q: A tumor is represented as T3N2M0. What stage does this indicate?

Stage 4. ### Explanation The TNM staging system (Tumor, Node, Metastasis) is the global standard for classifying the extent of cancer. In this case, the tumor is staged as **T3N2M0**, which corresponds to **Stage 4** (specifically Stage IV in many solid tumor classifications like Head and Neck or certain GI cancers). **1. Why Stage 4 is Correct:** In the TNM hierarchy, the involvement of regional lymph nodes is a significant prognostic indicator. While "Stage 4" is often associated with distant metastasis (M1), in several major staging systems (such as the AJCC 7th/8th editions for various squamous cell carcinomas), **N2 or N3 nodal involvement** automatically upgrades the disease to Stage IV, even in the absence of distant metastasis (M0). This reflects a high regional tumor burden and a prognosis similar to metastatic disease. **2. Why Other Options are Wrong:** * **Stage 1:** Typically represents small, localized tumors (T1) without any nodal involvement (N0) or metastasis (M0). * **Stage 2:** Usually involves larger localized tumors (T2) but still maintains an N0 status. * **Stage 3:** Generally involves T3 tumors with N0 or limited N1 nodal involvement. Once the nodal status reaches **N2**, the disease typically crosses the threshold into Stage 4. **3. NEET-PG High-Yield Pearls:** * **M1 = Always Stage 4:** Regardless of T or N status, any distant metastasis (M1) is automatically Stage IV. * **Nodal Status:** For many cancers, N0 = Stage I/II, N1 = Stage III, and N2/N3 = Stage IV. * **Exceptions:** Note that staging varies by organ (e.g., in Papillary Thyroid Cancer, age <55 years means any TNM without M1 is Stage I). * **Clinical vs. Pathological:** 'cTNM' is based on imaging/exam; 'pTNM' is based on surgical histopathology.

Q: A 60-year-old male is diagnosed with carcinoma of the right lung. CECT of the chest shows a 5x5 cm tumor in the upper lobe and another 2x2 cm tumor nodule in the middle lobe. Which of the following is the treatment of choice?

Surgery. ### Explanation **Correct Option: A. Surgery** The patient presents with two separate tumor nodules in different lobes of the same lung (Right Upper Lobe and Right Middle Lobe). According to the **TNM 8th Edition Staging System** for Lung Cancer: * Tumor nodules in the **same lobe** are classified as **T3**. * Tumor nodules in **different lobes of the same lung** are classified as **T4**. Despite being T4, if there is no evidence of mediastinal lymphadenopathy (N0/N1) or distant metastasis (M0), the disease is classified as **Stage IIIA**. In modern surgical oncology, Stage IIIA (T4N0-1) lung cancer is considered **resectable**. The treatment of choice is a surgical resection (e.g., pneumonectomy or bilobectomy) provided the patient has adequate pulmonary reserve. **Why Incorrect Options are Wrong:** * **B. Radiotherapy:** Primarily used for Stage IIIB/IV or in patients who are medically unfit for surgery. It is not the first-line treatment for resectable T4 disease. * **C. Chemotherapy:** Often used as neoadjuvant or adjuvant therapy in Stage III disease, but it is not the definitive "treatment of choice" when surgical cure is possible. * **D. Supportive treatment:** Reserved for end-stage (Stage IV) palliative care where curative intent is no longer feasible. **High-Yield Clinical Pearls for NEET-PG:** 1. **T-Staging Summary:** * Same Lobe = T3 * Same Lung (different lobe) = T4 * Opposite Lung = M1a 2. **Resectability vs. Operability:** Resectability depends on the tumor stage (TNM), while operability depends on the patient's fitness (FEV1, cardiac status). 3. **Gold Standard:** For early-stage Non-Small Cell Lung Cancer (NSCLC), anatomical resection (Lobectomy) with mediastinal lymph node dissection remains the gold standard.

Q: The Gompertzian curve is used to describe which of the following?

Cancer growth. **Explanation:** The **Gompertzian model** is a mathematical curve used to describe the growth kinetics of solid tumors. Unlike a simple exponential model, Gompertzian growth is **non-linear**. It suggests that early in the disease, tumor growth is rapid (exponential). However, as the tumor mass increases, the growth rate slows down due to limitations in nutrient supply, oxygen availability, and space (a phenomenon known as "growth fraction" reduction). This results in a sigmoid (S-shaped) curve. * **Why Option A is correct:** In clinical oncology, this curve explains why small micrometastases grow faster than large primary tumors. It is the basis for **adjuvant chemotherapy**, as smaller tumors have a higher growth fraction and are more susceptible to cell-cycle-specific drugs. * **Why Options B, C, and D are incorrect:** * **Wound healing (B):** Follows a predictable biological sequence (hemostasis, inflammation, proliferation, remodeling) but is not described by the Gompertzian curve. * **Haemorrhagic shock (C):** Usually categorized by the **ATLS Classification (Classes I-IV)** based on blood loss and physiological parameters. * **Nutritional requirements (D):** Calculated using the **Harris-Benedict equation** or indirect calorimetry. **High-Yield Clinical Pearls for NEET-PG:** 1. **Skipper’s Law:** States that a specific dose of chemotherapy kills a constant *fraction* of cells, not a constant *number* (Log-kill hypothesis). 2. **Doubling Time:** The time taken for a tumor to double in volume. For most solid tumors, this is roughly 2-3 months. 3. **Clinical Detection:** A tumor is usually clinically detectable when it reaches **1 cm in diameter** (approx. $10^9$ cells or 30 doublings). Death typically occurs at $10^{12}$ cells.

Q: What are the risk factors for anal carcinoma?

All of the above. **Explanation:** Anal carcinoma (specifically Squamous Cell Carcinoma) shares a similar pathophysiology with cervical cancer, primarily driven by persistent infection with high-risk strains of **Human Papillomavirus (HPV)**, most commonly types 16 and 18. * **HPV Infection (Option A):** This is the most significant risk factor, present in over 80-90% of cases. The virus integrates into the host genome, leading to the overexpression of E6 and E7 oncoproteins, which inactivate tumor suppressor genes p53 and Rb. * **Smoking (Option B):** Cigarette smoking is an independent risk factor for anal cancer. Carcinogens in tobacco smoke can reach the anal mucosa through systemic circulation or local deposition, promoting malignant transformation. * **Cervical Carcinoma (Option C):** Patients with a history of cervical, vaginal, or vulvar dysplasia/carcinoma are at a significantly higher risk. This is due to the "field effect" of HPV infection across the anogenital tract and shared lymphatic drainage patterns. **Clinical Pearls for NEET-PG:** 1. **HIV Status:** HIV-positive individuals (especially MSM - men who have sex with men) have the highest incidence of anal cancer due to immunosuppression and increased HPV prevalence. 2. **Anal Intraepithelial Neoplasia (AIN):** This is the precursor lesion (similar to CIN in the cervix). 3. **Anatomy:** Tumors above the dentate line are typically columnar/transition zone, while those below are squamous. 4. **Treatment:** Unlike most GI cancers, the primary treatment for anal canal SCC is **Nigro Protocol** (Chemoradiotherapy with 5-FU and Mitomycin C), not surgery. Surgery (Abdominoperineal Resection) is reserved for salvage.

Q: What is the primary treatment for extragonadal germ cell tumors?

Chemotherapy. **Explanation:** **Extragonadal Germ Cell Tumors (EGGCTs)** are rare neoplasms that arise outside the gonads, typically along the midline of the body (mediastinum, retroperitoneum, or pineal gland). 1. **Why Chemotherapy is Correct:** Germ cell tumors are inherently **exquisitely chemosensitive**. Because EGGCTs are often bulky, located in surgically challenging areas (like the anterior mediastinum), and have a high propensity for systemic spread, **platinum-based chemotherapy** (e.g., BEP regimen: Bleomycin, Etoposide, Cisplatin) is the primary treatment. It serves to treat both the primary site and any occult micrometastases simultaneously. 2. **Why Other Options are Incorrect:** * **Surgery:** While surgery plays a crucial role in managing *residual* masses after chemotherapy (especially in non-seminomatous GCTs to remove teratomas), it is rarely the primary treatment because these tumors are often invasive and unresectable at diagnosis. * **Radiotherapy:** Although seminomas are radiosensitive, chemotherapy is preferred as the primary modality because it addresses systemic disease and avoids the long-term toxicities of radiation (like secondary malignancies or radiation pneumonitis). * **Immunotherapy:** This is not currently a first-line standard of care for germ cell tumors, which are primarily managed with cytotoxic drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** The **mediastinum** is the most common extragonadal site in adults. * **Tumor Markers:** Always check **AFP and β-hCG**. Elevated AFP in a mediastinal mass strongly suggests a non-seminomatous EGGCT (Yolk sac component). * **Klinefelter Syndrome:** There is a strong clinical association between Klinefelter syndrome (47, XXY) and mediastinal germ cell tumors. * **Prognosis:** Primary mediastinal non-seminomatous GCTs are classified as "Poor Prognosis" according to the IGCCCG classification, regardless of marker levels.

Q: What is the most commonly performed surgery for sarcoma?

Wide excision. **Explanation:** The primary goal of surgical management in soft tissue sarcomas (STS) is to achieve a **R0 resection** (microscopically negative margins) to minimize the risk of local recurrence. **1. Why Wide Excision is Correct:** Wide excision is the standard of care for most sarcomas. It involves removing the tumor along with a **cuff of normal surrounding tissue** (usually 1–2 cm) in all dimensions. This ensures that microscopic extensions of the tumor (satellite nodules) beyond the pseudocapsule are removed, significantly reducing local recurrence rates while preserving limb function. **2. Why the Other Options are Incorrect:** * **Compartmental Excision/Exenteration:** This involves removing the entire anatomical compartment (from origin to insertion of muscles). While oncologically sound, it is highly morbid and rarely necessary today due to the efficacy of adjuvant radiotherapy. * **Excision (Marginal Excision):** This involves removing the tumor through its pseudocapsule. It leaves behind microscopic disease, leading to a high recurrence rate (up to 80%), and is generally considered inadequate. * **Enucleation:** This is "shelling out" the tumor. It is contraindicated for sarcomas as it inevitably leaves tumor cells behind, as the "capsule" seen in sarcomas is actually a compressed layer of tumor cells (pseudocapsule). **Clinical Pearls for NEET-PG:** * **Biopsy Principle:** The biopsy scar must be placed such that it can be completely incorporated into the definitive wide excision specimen. * **Staging:** The most important prognostic factor for STS is the **histological grade**. * **Adjuvant Therapy:** Radiotherapy is typically added to wide excision for high-grade, deep, or large (>5 cm) tumors to achieve local control comparable to amputation.

Q: Which of the following is NOT true about Marjolin's ulcer?

Spreads to local lymph nodes. **Explanation:** **Marjolin’s Ulcer** refers to a malignant transformation (most commonly Squamous Cell Carcinoma) occurring in chronic non-healing wounds, such as burn scars (most common), chronic osteomyelitis sinuses, or venous stasis ulcers. 1. **Why Option B is the Correct Answer (The "False" Statement):** The hallmark of Marjolin’s ulcer is that it arises in dense, avascular scar tissue. This cicatricial (scar) tissue lacks functional lymphatic channels. Consequently, despite being an aggressive malignancy, it **rarely spreads to local lymph nodes** early in the disease. If lymphadenopathy is present, it is often due to secondary infection rather than metastasis. 2. **Analysis of Other Options:** * **Option A (Locally Malignant):** This is true. It is an aggressive local malignancy that invades deep structures if left untreated. * **Option C (Painless Ulcer):** This is true. Because the ulcer develops within a chronic scar where nerve endings have been destroyed, the lesion is typically painless. This often leads to a delay in diagnosis. * **Option D (Squamous Cell Carcinoma):** This is true. SCC is the most common histological type (approx. 90%), followed by Basal Cell Carcinoma. **High-Yield Clinical Pearls for NEET-PG:** * **Latent Period:** The average time for malignant transformation is **25–30 years**. * **Diagnosis:** Requires an edge biopsy (wedge biopsy) from multiple sites. * **Treatment:** Wide local excision (with 2 cm margins) is the treatment of choice. Mohs surgery or amputation may be required depending on the site and depth. * **Prognosis:** Marjolin’s ulcer is generally more aggressive than primary SCC of the skin and has a higher recurrence rate.

Q: All of the following soft tissue sarcomas have a propensity for lymphatic spread except?

Neurofibrosarcoma. **Explanation:** The fundamental rule in surgical oncology is that **soft tissue sarcomas (STS) typically spread via the hematogenous route** (to the lungs), while carcinomas spread via the lymphatics. However, a specific subset of sarcomas defies this rule and frequently involves regional lymph nodes. **Why Neurofibrosarcoma is the correct answer:** Neurofibrosarcoma (also known as Malignant Peripheral Nerve Sheath Tumor or MPNST) follows the classic sarcoma pattern of hematogenous spread. It does **not** have a high propensity for lymphatic involvement. It is commonly associated with Neurofibromatosis Type 1 (NF1). **Why the other options are incorrect:** Options B, C, and D represent the rare exceptions that *do* spread via lymphatics. * **Synovial sarcoma:** One of the most common sarcomas to show nodal involvement, often occurring near joints in young adults. * **Rhabdomyosarcoma:** The most common soft tissue sarcoma in children; lymphatic spread is a key feature, especially in the alveolar subtype. * **Epithelioid sarcoma:** Characteristically involves lymph nodes and often presents as a firm nodule on the distal extremities (hand/forearm) of young adults. **High-Yield Clinical Pearls for NEET-PG:** To remember the sarcomas with lymphatic spread, use the mnemonic **"SCARE"** or **"CLEAR"**: * **S** – Synovial sarcoma * **C** – Clear cell sarcoma * **A** – Angiosarcoma * **R** – Rhabdomyosarcoma * **E** – Epithelioid sarcoma *Note: Epithelioid sarcoma is the most common STS to spread to lymph nodes in the upper extremity.*

Q: A 45-year-old patient presents with a 4 x 5 cm mass in the neck. Histopathological examination showed metastasis of squamous cell origin. The patient was thoroughly examined using laryngoscope, whole body CT and PET CT. No primary is found and the diagnosis of Carcinoma of Unknown Primary (CUP) is made. What is the TNM staging as per AJCC?

T0N2M0. ### Explanation **1. Understanding the Correct Answer (T0N2M0):** In cases of **Carcinoma of Unknown Primary (CUP)**, by definition, the primary tumor cannot be identified despite a thorough diagnostic workup (clinical exam, endoscopy, and imaging like PET-CT). * **T (Tumor):** Since no primary site is found, the staging is designated as **T0**. * **N (Node):** The patient has a **4 x 5 cm** mass. According to the AJCC 8th Edition for Head and Neck cancers (specifically HPV-negative or non-viral related squamous cell carcinoma), a single ipsilateral lymph node **>3 cm but ≤6 cm** in greatest dimension is classified as **N2a**. Therefore, the nodal status is **N2**. * **M (Metastasis):** There is no mention of distant organ involvement, so it is **M0**. Combining these, the stage is **T0N2M0**. **2. Why Other Options are Incorrect:** * **A (T1N1M0) & B (T1N2M0):** These are incorrect because **T1** implies a primary tumor of $\leq$ 2 cm has been identified. In CUP, the primary is never T1; it is always T0. * **C (T0N1M0):** While T0 is correct, **N1** refers to a single ipsilateral lymph node **$\leq$ 3 cm**. This patient’s mass is 5 cm, which exceeds the N1 threshold. **3. Clinical Pearls for NEET-PG:** * **Definition of CUP:** Metastatic disease proven by biopsy where the primary site remains undetected after "comprehensive" evaluation (including PET-CT and Pan-endoscopy). * **Most Common Site:** The most common histology for CUP in the neck is **Squamous Cell Carcinoma (SCC)**. * **Diagnostic Gold Standard:** If imaging fails, **directed biopsies** (tongue base, tonsillectomy, and nasopharynx) are performed, as these are the most common "hidden" primary sites. * **AJCC 8th Ed Update:** For neck nodes, always check for **Extranodal Extension (ENE)**. If ENE is present, a single node $\leq$ 3cm becomes N2a, and any node >3cm becomes N3b. (In this question, ENE was not mentioned, so we use standard size criteria).

Q: Which of the following is a common tumor of the anterior mediastinum?

Thymoma. ### Explanation The mediastinum is anatomically divided into compartments, each associated with specific pathologies. The **Anterior Mediastinum** (the space between the sternum and the pericardium) is the most common site for mediastinal masses. **1. Why Thymoma is Correct:** Thymoma is the most common primary tumor of the anterior mediastinum in adults. The "4 Ts" mnemonic is a high-yield tool for remembering anterior mediastinal masses: * **T**hymoma (Most common) * **T**eratoma (and other Germ Cell Tumors) * **T**errible Lymphoma * **T**hyroid (Retrosternal Goiter) **2. Analysis of Incorrect Options:** * **Neurogenic Fibroma (Option B):** These are the most common tumors of the **Posterior Mediastinum**. They arise from spinal nerve roots or intercostal nerves. * **Lymphoma (Option C):** While Lymphoma is a common anterior mediastinal mass, **Thymoma** is statistically more frequent as a primary surgical pathology in this compartment. Lymphoma often presents with systemic symptoms and bulky lymphadenopathy. * **Meningocele (Option D):** This is a rare cystic lesion found in the **Posterior Mediastinum**, often associated with vertebral defects. **3. Clinical Pearls for NEET-PG:** * **Thymoma Association:** Approximately 30–50% of patients with thymoma have **Myasthenia Gravis**. Conversely, 15% of patients with Myasthenia Gravis are found to have a thymoma. * **Most Common Overall:** Neurogenic tumors are the most common mediastinal masses in children (Posterior), while Thymomas are the most common in adults (Anterior). * **Imaging:** Contrast-Enhanced CT (CECT) is the gold standard for evaluating mediastinal compartments.

Question 1

A tumor is represented as T3N2M0. What stage does this indicate?

Accepted Answer

Stage 4

Answer

Stage 1

Answer

Stage 2

Answer

Stage 3

Question 2

A 60-year-old male is diagnosed with carcinoma of the right lung. CECT of the chest shows a 5x5 cm tumor in the upper lobe and another 2x2 cm tumor nodule in the middle lobe. Which of the following is the treatment of choice?

Accepted Answer

Surgery

Answer

Radiotherapy

Answer

Chemotherapy

Answer

Supportive treatment

Question 3

The Gompertzian curve is used to describe which of the following?

Accepted Answer

Cancer growth

Answer

Wound healing rate

Answer

Haemorrhagic shock

Answer

Nutritional requirements in surgical patients

Question 4

What are the risk factors for anal carcinoma?

Accepted Answer

All of the above

Answer

Human Papillomavirus (HPV) infection

Answer

Smoking

Answer

Cervical carcinoma

Question 5

What is the primary treatment for extragonadal germ cell tumors?

Accepted Answer

Chemotherapy

Answer

Radiotherapy

Answer

Surgery

Answer

Immunotherapy

Question 6

What is the most commonly performed surgery for sarcoma?

Accepted Answer

Wide excision

Answer

Compartmental excision/exenteration

Answer

Excision

Answer

Enucleation

Question 7

Which of the following is NOT true about Marjolin's ulcer?

Accepted Answer

Spreads to local lymph nodes

Answer

Locally malignant

Answer

Painless ulcer

Answer

Squamous cell carcinoma

Question 8

All of the following soft tissue sarcomas have a propensity for lymphatic spread except?

Accepted Answer

Neurofibrosarcoma

Answer

Synovial sarcoma

Answer

Rhabdomyosarcoma

Answer

Epithelioid sarcoma

Question 9

A 45-year-old patient presents with a 4 x 5 cm mass in the neck. Histopathological examination showed metastasis of squamous cell origin. The patient was thoroughly examined using laryngoscope, whole body CT and PET CT. No primary is found and the diagnosis of Carcinoma of Unknown Primary (CUP) is made. What is the TNM staging as per AJCC?

Accepted Answer

T0N2M0

Answer

T1N1M0

Answer

T1N2M0

Answer

T0N1M0

Question 10

Which of the following is a common tumor of the anterior mediastinum?

Accepted Answer

Thymoma

Answer

Neurogenic Fibroma

Answer

Lymphoma

Answer

Meningocele

Surgical Oncology Principles — MCQs

Surgical Oncology Principles — MCQs

On this page

Practice by Chapter

Want unlimited practice?